Arxada is a Basel-headquartered specialty chemicals company that manufactures science-based chemical and biotechnological products and provides contract development and manufacturing. Its global footprint includes 24 production sites and 14 R&D centers, and its CDMO combines industrial biotechnology with chemical synthesis, from development work to multi-ton production.
Wacker Chemie AGFor more than 100 years, Wacker Chemie AG has developed and manufactured specialty chemicals and biotechnology solutions for customers in markets around the world. The Munich-based company combines product and process innovation with a global operating network of 27 production sites, 47 sales offices and more than 16,000 employees. Through Wacker Biotech, it also brings more than 30 years of experience in developing and validating biopharmaceutical manufacturing processes.ALLENTOWN, PA
MCA Technologies GmbHFounded in Switzerland in 2003 as an extension of Medchemadvice, established in 1989, MCA Technologies GmbH develops and supplies specialty chemicals and life-sciences products while supporting clients’ R&D and business development. Its work combines strategic sourcing with collaborative development of tailored technologies and processes, including proprietary halogen-free fire retardants and DPP pigment technology. The company also arranges contract research and manufacturing through capabilities in biotechnology, fermentation and chemistry.HARRISBURG, PA
AbzenaWith more than 20 years of scientific expertise, Abzena is an integrated biologics CDMO and CRO serving biotech and pharmaceutical companies worldwide. Its six facilities in the United States and United Kingdom are connected around a single development pathway, helping customers move complex drug candidates from early discovery toward clinical and commercial supply. Abzena has worked with more than 500 customers globally.BRISTOL, PA
LonzaFounded in Switzerland in 1897, Lonza is a global contract development and manufacturing organization that helps pharmaceutical and biotechnology companies turn new medicines into clinical and commercial therapies. Its network of more than 30 sites and approximately 19,000 employees spans five continents, with capabilities ranging from biologics and small-molecule drug products to cell and gene therapies and mRNA manufacturing. In Bend, Oregon, the former Bend Research team brings more than 45 years of specialized experience in improving drug solubility and bioavailability.WALKERSVILLE, MD